darleukin
Recombinant proteinexperimentalADC
Clinical trial activity
2 trials · 13 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jun 30, 2018 (NCT03567889)
Timeline
Indications
Mechanism of action
- Interleukin-2Supplementation
IL2 supplementation
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- IL2
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS2OQ3OPV2F8 ↗
- ChEMBLCHEMBL4297740 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03705403 | Phase 2 | Dec 1, 2018 | Catholic University of Sacred Heart, Rome, Ghent University, Katholieke Universiteit Leuven, Maastricht University, Netherlands Cancer Institute, Radboud University, Technical University of Dresden, Université catholique de Louvain, University of Lille, University of London, University of Tuebingen |
| NCT03567889 | Phase 3 | Jun 30, 2018 | Philogen S.p.A., University of South Florida |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Catholic University of Sacred Heart, Rome | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Ghent University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Maastricht University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Netherlands Cancer Institute | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Philogen S.p.A. | For profit | 1 | 1 | 1 | 2018 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Technical University of Dresden | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Université catholique de Louvain | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Lille | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of South Florida | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Tuebingen | Academic/Hospital | 1 | 0 | 1 | 2018 |
13 organizations
Page 1 / 1